Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06561542
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-06
Brief Title:
A Phase I Study of LX22001 for Injection in Healthy Subjects
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase I Escalating Single and Multiple Dose Study of LX22001 for Injection to Evaluate the Safety Tolerability Pharmacokinetics Pharmacodynamics and Bioavailability in Healthy Subjects
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study to evaluate the safety and tolerability pharmacokineticspharmacodynamics PKPD parameters of an escalating single doserepeat doses of LX22001 for injection in healthy subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None